Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Saliva pharmacokinetics of amikacin and flucloxacillin in neonates
NL-OMON55002Active, not recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of amikacin and flucloxacillin in bacterial disease and late-onset neonatal sepsis (LONS), sponsored by Amsterdam University Medical Center. Started Oct 2020; status: active, not recruiting.
02
Drugs
amikacinflucloxacillin
03
Conditions
bacterial diseaselate-onset neonatal sepsis (LONS)
Beyond the preview
Go deeper on NL-OMON55002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON55002.